Top compounds associated with response to UTS2R

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Irinotecan	gCSI	pan-cancer	AAC	-0.15	0.008
mRNA	Cisplatin	GDSC1000	pan-cancer	AAC	-0.091	0.008
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.097	0.008
mRNA	Roscovitine	GDSC1000	pan-cancer	AAC	0.14	0.009
mRNA	tubastatin A	CTRPv2	pan-cancer	AAC	0.13	0.009
mRNA	AT7867	CTRPv2	pan-cancer	AAC	-0.089	0.01
mRNA	Erlotinib	GDSC1000	pan-cancer	AAC	0.12	0.01
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.085	0.01
mRNA	navitoclax:birinapant (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.09	0.01
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.078	0.01

Download CSV